Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Could Goserelin Used With Chemotherapy Help Preserve Fertility?

Could Goserelin Used With Chemotherapy Help Preserve Fertility?

According to research published in the British medical journal, goserelin administered with chemotherapy for cancer may help preserve fertility by reducing the risk of ovarian failure and early menopause.

Chemotherapy is one of the most fundamental cancer treatments, providing a significant survival advantage. Depending on breast cancer stage, it is sometimes the main treatment and more often an adjunct (adjuvant) treatment. It is used as the main treatment particularly in advanced cancers spread to distant tissue, and as an adjunct to shrink tumors before surgery or kill possible remaining cancer cells afterward. However, side effects, particularly fertility loss, can sometimes cause breast cancer patients to refuse it. Studies are therefore investigating ways to reduce these effects, and goserelin is among the agents under investigation.

Goserelin is a synthetic form of the hormone GnRH produced in the body. GnRH stimulates the pituitary to release certain hormones, which stimulate estrogen and androgen release from the testes or ovaries. However, externally administered GnRH suppresses the pituitary-testis/ovary pathway, thereby inactivating the testes or ovaries. This suggested that goserelin given with chemotherapy might suppress the ovaries and protect them from chemotherapy damage. A study on this subject was recently published in the British Medical Journal.

The study enrolled premenopausal women with hormone receptor-negative (resistant to hormonal treatment) breast cancer: 218 women were divided into 2 groups. One received standard chemotherapy alone, while the other received chemotherapy with goserelin. Patients were followed for 2 years to assess ovarian failure (infertility). Infertility occurred in %22 of the chemotherapy-only group compared with %8 of the goserelin-plus-chemotherapy group. Pregnancy also occurred in %22 of the goserelin group versus %11 in the other group.

In conclusion, chemotherapy has an indispensable role in breast cancer and many other cancers. However, its side effects can seriously affect quality of life. Fertility loss is a relatively common side effect of chemotherapy regimens. The possibility that goserelin administered with chemotherapy may preserve fertility by reducing ovarian failure and early menopause is therefore very encouraging. However, as the research team notes, some data are missing, and caution is advisable when applying these findings clinically.

Sources

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Could Goserelin Used With Chemotherapy Help Preserve Fertility?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy